Trexquant Investment’s Genomic Health, Inc. GHDX Stock Holding History

Trexquant Investment’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,543	Closed	-$904K	–	1235
2019 Q2	$904K	Sell	15,543 -8,415	-35%	-$499K	0.08%	340
2019 Q1	$1.68M	Sell	23,958 -7,735	-24%	-$574K	0.12%	252
2018 Q4	$2.04M	Buy	31,693 +28,823	+1,004%	+$2.02M	0.13%	234
2018 Q3	$202K	Buy	+2,870	New	+$168K	0.02%	821
2018 Q2	–	Sell	-17,610	Closed	-$551K	–	1390
2018 Q1	$551K	Buy	+17,610	New	+$584K	0.04%	601
2016 Q2	–	Sell	-17,118	Closed	-$424K	–	1223
2016 Q1	$424K	Buy	17,118 +11,318	+195%	+$311K	0.05%	612
2015 Q4	$204K	Buy	+5,800	New	+$155K	0.02%	937
2015 Q2	–	Sell	-22,000	Closed	-$672K	–	1350
2015 Q1	$672K	Buy	+22,000	New	+$699K	0.07%	567

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Trexquant Investment's GHDX Position: Q3 2019 in Review

Trexquant Investment sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 15,543 shares — an estimated $904K sold.

Trexquant Investment first reported a position in GHDX in Q1 2015 and held it in 8 quarters. The position peaked at $2.04M in Q4 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

Trexquant Investment reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
Trexquant Investment sold 15,543 Genomic Health, Inc. shares in Q3 2019, an estimated $904K.
Trexquant Investment first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 8 quarters.
Trexquant Investment's Genomic Health, Inc. position peaked at $2.04M in Q4 2018.
221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.